View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Catalent
17 February 2017

Catalent Plans to Expand Softgel Development and Manufacturing Capabilities and Capacity Following Accucaps Aqcuisition

Catalent has announced it has completed the acquisition of Accucaps Industries, a Canada-based developer and manufacturer of Over-the-Counter (OTC), high-potency, and conventional pharmaceutical softgels. Financial details of the transaction have not been disclosed.

The acquisition complements Catalent’s global OTC and prescription pharmaceutical softgel capabilities, as well as capacity, with the addition of a portfolio of products supplied to pharmaceutical companies in North America. Two state-of-the-art facilities were also included, offering integrated softgel development, manufacturing, and packaging, as well as strengthening Catalent’s ability to offer its customers turnkey solutions.

More than 500 Accucaps employees, at two facilities in Windsor and Strathroy, will join Catalent’s global network of 11 Softgel Technologies facilities. The Accucaps facilities house sizeable blistering, bottling and other packaging capabilities, as well as high-potency prescription softgel development and manufacturing expertise that are complementary to Catalent’s.

Catalent utilised two technologies targeting duodenal and sublingual biological barriers through a parallel screening approach to assess the oral delivery potential of Salmon Calcitonin.
Catalent Pharma provided London-based pharmaceutical company Trio Medicines with three formulation technologies and four prototypes showing improved solubility and bioavailability for an acetyl prodrug of...
With Catalent's team of packaging experts and extensive cold chain capabilities, this case study discusses the creation of a custom packaging and distribution solution to...
The number of clinical trials in the Asia-Pacific (APAC) region is growing as sponsors tap into expanding pharmaceutical market.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology